Information
Overview
- Summary
- Plasmapp is a bio-plasma deep-tech company founded in 2015 as a spin-off from the KAIST Department of Physics, specializing in the development and commercialization of plasma-based medical solutions. The company offers a diverse range of medical devices, including low-temperature plasma sterilizers, implant surface activators, and plasma stimulation therapy devices. Recognized for its innovative technology, Plasmapp has been selected as a preliminary unicorn, one of the top 100 materials, parts, and equipment startups, and an innovative medical device company, demonstrating its technological prowess both domestically and internationally. With over 187 patent applications and the Korea Technology Grand Prize, the company is actively expanding its business into the global medical device market.Plasmapp is a bio-plasma deep-tech company founded in 2015 as a spin-off from the KAIST Department of Physics, specializing in the development and commercialization of plasma-based medical solutions. The company offers a diverse range of medical devices, including low-temperature plasma sterilizers, implant surface activators, and plasma stimulation therapy devices. Recognized for its innovative technology, Plasmapp has been selected as a preliminary unicorn, one of the top 100 materials, parts, and equipment startups, and an innovative medical device company, demonstrating its technological prowess both domestically and internationally. With over 187 patent applications and the Korea Technology Grand Prize, the company is actively expanding its business into the global medical device market.
- Key Products/Technologies
- **Low-Temperature Plasma Sterilizers (STERLINK Series)**: These are low-temperature plasma sterilizers featuring the world's first direct injection technology, enabling ultra-fast sterilization within 5-7 minutes at temperatures below 50 degrees Celsius. Models include STERLINK 15sp, STERLINK mini, STERLINK Lite, STERLINK Lite Plus, and STERLINK 510M, with the STERLINK mini notably extending instrument lifespan by 3 times and increasing surgical tool turnover by over 30 times compared to high-pressure steam sterilizers, offering significant economic efficiency. The STERPACK sterilization pouch, developed with proprietary impermeable film technology, ensures a clean, residue-free state after sterilization and has received US FDA approval.**Low-Temperature Plasma Sterilizers (STERLINK Series)**: These are low-temperature plasma sterilizers featuring the world's first direct injection technology, enabling ultra-fast sterilization within 5-7 minutes at temperatures below 50 degrees Celsius. Models include STERLINK 15sp, STERLINK mini, STERLINK Lite, STERLINK Lite Plus, and STERLINK 510M, with the STERLINK mini notably extending instrument lifespan by 3 times and increasing surgical tool turnover by over 30 times compared to high-pressure steam sterilizers, offering significant economic efficiency. The STERPACK sterilization pouch, developed with proprietary impermeable film technology, ensures a clean, residue-free state after sterilization and has received US FDA approval.
- **Implant Surface Activators (ACTILINK Series)**: These devices remove hydrocarbons and impurities attached to implant surfaces within 1 minute and enhance surface energy to improve biocompatibility. Utilizing vacuum plasma technology, they boost the safety and performance of implants, applicable to various implants in dentistry, orthopedics, and plastic surgery. The ACTILINK Reborn model also received a main award at the IDEA Design Awards, recognizing its design excellence.**Implant Surface Activators (ACTILINK Series)**: These devices remove hydrocarbons and impurities attached to implant surfaces within 1 minute and enhance surface energy to improve biocompatibility. Utilizing vacuum plasma technology, they boost the safety and performance of implants, applicable to various implants in dentistry, orthopedics, and plastic surgery. The ACTILINK Reborn model also received a main award at the IDEA Design Awards, recognizing its design excellence.
- **Plasma Stimulation Therapy Devices (STIMLINK)**: This solution focuses on bio-tissue stimulation therapy using plasma, aiming for effects such as accelerated skin healing, scar improvement, and infection prevention. The company is currently securing core technologies through R&D and plans to expand its business into the broader healthcare industry.**Plasma Stimulation Therapy Devices (STIMLINK)**: This solution focuses on bio-tissue stimulation therapy using plasma, aiming for effects such as accelerated skin healing, scar improvement, and infection prevention. The company is currently securing core technologies through R&D and plans to expand its business into the broader healthcare industry.
- **Plasma Endo**: A new product targeting the dental endodontic treatment market, this therapeutic solution incorporates ultra-precision control technology to ensure both procedural stability and convenience. It represents a strategic move to expand the company's business from sterilization equipment to the treatment solutions sector.**Plasma Endo**: A new product targeting the dental endodontic treatment market, this therapeutic solution incorporates ultra-precision control technology to ensure both procedural stability and convenience. It represents a strategic move to expand the company's business from sterilization equipment to the treatment solutions sector.
- Core Advantages
- **Unique Plasma Original Technology**: Leveraging its KAIST physics lab spin-off origins, the company possesses specialized plasma technology expertise, developing the world's first direct injection low-temperature plasma sterilizers and implant surface activators, thus securing a technological lead.**Unique Plasma Original Technology**: Leveraging its KAIST physics lab spin-off origins, the company possesses specialized plasma technology expertise, developing the world's first direct injection low-temperature plasma sterilizers and implant surface activators, thus securing a technological lead.
- **Fast and Safe Low-Temperature Sterilization Solution**: Compared to conventional high-temperature/high-pressure sterilization methods, its low-temperature sterilization (below 50 degrees Celsius) is over 10 times faster, preventing thermal damage to medical devices, maximizing surgical tool turnover, and ensuring residue-free safety after sterilization.**Fast and Safe Low-Temperature Sterilization Solution**: Compared to conventional high-temperature/high-pressure sterilization methods, its low-temperature sterilization (below 50 degrees Celsius) is over 10 times faster, preventing thermal damage to medical devices, maximizing surgical tool turnover, and ensuring residue-free safety after sterilization.
- **Global Market Certifications and Expansion**: Plasmapp has obtained numerous medical device certifications from major countries, including US FDA, European CE MDR, Chinese CVC, and Russian RZN, establishing a foundation for global market entry. The establishment of US and European subsidiaries and partnerships with 12 countries further expands its global business reach.**Global Market Certifications and Expansion**: Plasmapp has obtained numerous medical device certifications from major countries, including US FDA, European CE MDR, Chinese CVC, and Russian RZN, establishing a foundation for global market entry. The establishment of US and European subsidiaries and partnerships with 12 countries further expands its global business reach.
- **Extensive Intellectual Property and Awards**: The company holds over 187 patent applications and 286 intellectual property rights, including designs and trademarks, reinforcing its technological exclusivity. It has received numerous accolades such as the Korea Technology Grand Prize, Minister of Health and Welfare Award, and the IDEA Design Award, recognizing its technological innovation and excellence.**Extensive Intellectual Property and Awards**: The company holds over 187 patent applications and 286 intellectual property rights, including designs and trademarks, reinforcing its technological exclusivity. It has received numerous accolades such as the Korea Technology Grand Prize, Minister of Health and Welfare Award, and the IDEA Design Award, recognizing its technological innovation and excellence.
- **Extended Medical Device Lifespan and Cost Savings**: The low-temperature sterilization method minimizes damage to expensive medical devices, extending their lifespan, while rapid sterilization reduces the need for extensive medical device inventory, contributing to hospital operational cost savings.**Extended Medical Device Lifespan and Cost Savings**: The low-temperature sterilization method minimizes damage to expensive medical devices, extending their lifespan, while rapid sterilization reduces the need for extensive medical device inventory, contributing to hospital operational cost savings.
- **Strategic Partnerships and Customer Base Expansion**: A 1 billion KRW product supply contract and joint marketing collaboration with MegaGen Implant strengthen its dominance in the domestic and international dental markets. Furthermore, partnerships with leading US medical device distributor QMED and ophthalmic equipment specialist Advancing Eyecare (AEC) mark its official entry into the US ophthalmic market.**Strategic Partnerships and Customer Base Expansion**: A 1 billion KRW product supply contract and joint marketing collaboration with MegaGen Implant strengthen its dominance in the domestic and international dental markets. Furthermore, partnerships with leading US medical device distributor QMED and ophthalmic equipment specialist Advancing Eyecare (AEC) mark its official entry into the US ophthalmic market.
- Target Industrie
- Medical sterilization market (hospitals, dental clinics, operating rooms, central sterile supply departments)Medical sterilization market (hospitals, dental clinics, operating rooms, central sterile supply departments)
- Dental implant market (dental clinics, implant manufacturers)Dental implant market (dental clinics, implant manufacturers)
- Orthopedic implant marketOrthopedic implant market
- Plastic surgery implant marketPlastic surgery implant market
- Dermatology and rehabilitation medical marketDermatology and rehabilitation medical market
- Ophthalmic surgery market (ophthalmic clinics, ambulatory surgical centers)Ophthalmic surgery market (ophthalmic clinics, ambulatory surgical centers)
- Surface treatment of secondary battery separator films (industrial use)Surface treatment of secondary battery separator films (industrial use)
- Major Markets
- Thailand, Japan, ChinaThailand, Japan, China
- European Union (CE MDR certification acquired), Italy, RussiaEuropean Union (CE MDR certification acquired), Italy, Russia
- United States (FDA certification acquired and US subsidiary established)United States (FDA certification acquired and US subsidiary established)
- ColombiaColombia
- Certifications/Patents
- Over 187 patent applications and 286 intellectual property rightsOver 187 patent applications and 286 intellectual property rights
- Korea Technology Grand PrizeKorea Technology Grand Prize
- US FDA certification (STERLINK 15sp, STERLINK mini, STERLOAD mini, STERPACK)US FDA certification (STERLINK 15sp, STERLINK mini, STERLOAD mini, STERPACK)
- European CE MDR certification (ACTILINK)European CE MDR certification (ACTILINK)
- China CVC certification (ACTILINK)China CVC certification (ACTILINK)
- Russian Federal Service for Surveillance in Healthcare (RZN) certificationRussian Federal Service for Surveillance in Healthcare (RZN) certification
- Colombia INVIMA medical device certificationColombia INVIMA medical device certification
- Ministry of Health and Welfare Innovative Medical Device Company certification (extended until 2028)Ministry of Health and Welfare Innovative Medical Device Company certification (extended until 2028)
- Ministry of Trade, Industry and Energy Excellent Development Innovative Product designationMinistry of Trade, Industry and Energy Excellent Development Innovative Product designation
- Ministry of Trade, Industry and Energy New Excellent Technology (NET) certificationMinistry of Trade, Industry and Energy New Excellent Technology (NET) certification
- Ministry of Trade, Industry and Energy New Excellent Product (NEP) certificationMinistry of Trade, Industry and Energy New Excellent Product (NEP) certification
- Ministry of Health and Welfare New Health Technology (NET) certificationMinistry of Health and Welfare New Health Technology (NET) certification
- Minister of Health and Welfare Commendation (2022 Health Industry Performance Exchange)Minister of Health and Welfare Commendation (2022 Health Industry Performance Exchange)
- Three Million Dollar Export Tower Award (2021)Three Million Dollar Export Tower Award (2021)
- Korea Invention Patent Exhibition Commissioner of the Korean Intellectual Property Office AwardKorea Invention Patent Exhibition Commissioner of the Korean Intellectual Property Office Award
- Prime Minister's Commendation for Venture MeritsPrime Minister's Commendation for Venture Merits
- Silver and Bronze Awards at the Seoul International Invention FairSilver and Bronze Awards at the Seoul International Invention Fair
- Innovative Company National Representative 100 certificationInnovative Company National Representative 100 certification
- US IDEA Design Award Main Award (ACTILINK Reborn)US IDEA Design Award Main Award (ACTILINK Reborn)
Introduction
Location
476 Gangnam-daero, Gangnam District, Seoul, South Korea
클릭하여 위치 살펴보기
